400,0
+0,00%
2026-10-16
Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +12.3% | +11.2% | 2 / 3 | +99.6% | +2.87 pp | +9.66 pp | +10.9% | -0.78 | — | 168 | +99,6% | −12,7 | +12,3% | — | -0.24 | — |
| Pts | 0 | 0 | 8 | 12 | 8 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 400,0 (close price on 2026-10-16)EPS (TTM): −2.278,5
Financial charts
1.Revenue & growth
VND bn168Q2/26
1.Revenue & growth
VND bn168Q2/26
2.Profit & growth
VND bn-14,5Q2/26
3.Profit mix (Penman)
VND bn-62,0Q2/26
4.Margins & cost structure
%-5.9%Q2/26
5.Returns & cash cycle
% · days
6.Earnings quality & cash
VND bn24,1Q2/26
7.Asset structure
VND bn787Q2/26
8.Funding & debt health
VND bn · times787Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %-0,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-533Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26